Literature DB >> 29895998

First-Trimester Uterine Artery Pulsatility Index and Maternal Serum PAPP-A and PlGF in Prediction of Preeclampsia in Primigravida.

Mostafa Abdo Ahmed Salem1, Islam Mohamed Magdi Ammar1.   

Abstract

BACKGROUND: Preeclampsia is a heterogeneous disorder affecting different body systems and frequently associated with morbidity and mortality. Early preeclampsia prediction will reduce this associated morbidity and mortality as it will give the chance for frequent maternal and fetal surveillance and application of prophylactic procedures.
OBJECTIVE: The aim of this work is to evaluate the role of mean pulsatility index (PI) of the uterine arteries and maternal serum concentrations of pregnancy-associated plasma protein A (PAPP-A) and placental growth factor (PlGF) in early preeclampsia prediction in primigravida. PATIENTS AND METHODS: Three hundred primigravida attending the antenatal care clinic in Zagazig University Hospitals were included in the study. The mean PI of the uterine arteries was calculated. Maternal serum levels of PAPP-A and PIGF were analyzed by specific immunoassay.
RESULTS: Three hundred women were included in the final analysis, of them 30 patients (10%) suffered from preeclampsia. There was a significant difference between preeclamptic and normal women as regards the mean PI of the uterine arteries and levels of PAPP-A and PIGF at 11-13 weeks. When combining the cutoff levels of the three methods, mean PI of the uterine arteries ≥1.69, PAPP-A assay <0.96 multiple of median (MoM) and PlGF assay <0.91 MoM, the sensitivity, specificity, positive predictive value, negative predictive value and overall accuracy were 56.7, 99.3, 89.5, 95.4 and 67%, respectively.
CONCLUSION: The combined measurement of maternal serum PAPP-A and PlGF concentrations and mean PI of the uterine arteries at 11-13 weeks of pregnancy may help to predict preeclampsia in primigravida when other parameters of preeclampsia prediction are normal. However, we need more studies on larger and variable populations to evaluate the use of those combined methods in preeclampsia prediction.

Entities:  

Keywords:  PAPP-A; PIGF; Preeclampsia; Pulsatility index

Year:  2017        PMID: 29895998      PMCID: PMC5972089          DOI: 10.1007/s13224-017-1012-5

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  17 in total

1.  Screening for pre-eclampsia by using changes in uterine artery Doppler indices with advancing gestation.

Authors:  Raffaele Napolitano; Karen Melchiorre; Tiziana Arcangeli; Tiran Dias; Amar Bhide; Basky Thilaganathan
Journal:  Prenat Diagn       Date:  2012-02       Impact factor: 3.050

2.  First-trimester screening for pre-eclampsia and fetal growth restriction: a test seeking both a treatment and an optimal timing.

Authors:  C Lees
Journal:  Ultrasound Obstet Gynecol       Date:  2010-06       Impact factor: 7.299

Review 3.  Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review.

Authors:  Sylwia Kuc; Esther J Wortelboer; Bas B van Rijn; Arie Franx; Gerard H A Visser; Peter C J I Schielen
Journal:  Obstet Gynecol Surv       Date:  2011-04       Impact factor: 2.347

Review 4.  Placental origins of preeclampsia: challenging the current hypothesis.

Authors:  Berthold Huppertz
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

Review 5.  First trimester uterine artery Doppler for the prediction of preeclampsia and foetal growth restriction.

Authors:  L Carbillon
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-30

6.  Variation of papp-a level in the first trimester of pregnancy and its clinical outcome.

Authors:  Mithil Patil; T M Panchanadikar; Girija Wagh
Journal:  J Obstet Gynaecol India       Date:  2013-12-01

7.  First-trimester prediction of preeclampsia in nulliparous women at low risk.

Authors:  Leslie Myatt; Rebecca G Clifton; James M Roberts; Catherine Y Spong; John C Hauth; Michael W Varner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Marshall W Carpenter; Jay D Iams; Anthony Sciscione; Margaret Harper; Jorge E Tolosa; George Saade; Yoram Sorokin; Garland D Anderson
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

8.  Serum tumor necrosis factor-α level and uterine artery Doppler indices at 11-13 weeks' gestation for preeclampsia screening in low-risk pregnancies: a prospective observational study.

Authors:  Mostafa Fouad Gomaa; Ahmed Hamdy Naguib; Khaled Hassan Swedan; Samia Salah Abdellatif
Journal:  J Reprod Immunol       Date:  2015-03-21       Impact factor: 4.054

9.  Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.

Authors:  Anna-Karin Wikström; Anders Larsson; Ulf J Eriksson; Peppi Nash; Solveig Nordén-Lindeberg; Matts Olovsson
Journal:  Obstet Gynecol       Date:  2007-06       Impact factor: 7.661

10.  The role of maternal serumbeta-HCG and PAPP-A levels at gestational weeks 10 to 14 in the prediction of pre-eclampsia.

Authors:  Ozkan Ozdamar; Ismet Gun; Ugur Keskin; Necmettin Kocak; Ercument Mungen
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

View more
  4 in total

1.  Clinical Application of a Multiparameter-Based Nomogram Model in Predicting Preeclampsia.

Authors:  Wenyue Chen; Sufang Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-13       Impact factor: 2.650

2.  Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Ladislav Krofta
Journal:  Biomedicines       Date:  2022-01-25

3.  The MEG3 lncRNA promotes trophoblastic cell growth and invasiveness in preeclampsia by acting as a sponge for miR-21, which regulates BMPR2 levels.

Authors:  Huyi Liu; Xiangdao Cai; Jia Liu; Fengxiang Zhang; Andong He; Ruiman Li
Journal:  Eur J Histochem       Date:  2021-11-25       Impact factor: 3.188

4.  Beneficial effects of nicotinamide on the mouse model of preeclampsia.

Authors:  Phillip K Huynh; Nobuyuki Takahashi; Nobuyo Maeda-Smithies; Feng Li
Journal:  OA J Pregnancy Child Care       Date:  2018-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.